This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies | MicrobiomeTrials
← Back to trials NCT06904066
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-30Est. Completion: 2029-04-30
Enrollment target: 86 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in B-cell Acute Lymphoblastic Leukemia Diffuse Large B-cell Lymphoma Burkitt Lymphoma Neuroblastoma Ewing Sarcoma
Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab…
Los Angeles, United States Est. completion Mar 31, 2029
Breast Cancer Breast Carcinoma Cancer of the Breast Malignant Neoplasm of Breast
Background:
Breast cancer is the most common cancer among women. It can often spread to the liver, lungs, bones, or bra…
Bethesda, United States Est. completion Jul 1, 2033
Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes (MDS) Myeloproliferative Neoplasm
Cancer and treatment-related cognitive changes, such as thinking or remembering, hinder resumption of normal routine and…
Omaha, United States Est. completion Jul 2027